amobarbital has been researched along with Infant, Newborn, Diseases in 2 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, WM | 1 |
| Salimpour, R | 1 |
2 other studies available for amobarbital and Infant, Newborn, Diseases
| Article | Year |
|---|---|
[Tetanus neonatorum].
Topics: Amobarbital; Anti-Bacterial Agents; Chloral Hydrate; Chlorpromazine; Erythromycin; Humans; Hypnotics | 1970 |
Amobarbital chloropromazine in the treatment of tetanus neonatorum.
Topics: Amobarbital; Chlorpromazine; Female; Humans; Hypothermia; Infant, Newborn; Infant, Newborn, Diseases | 1971 |